DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE QUANTITATIVE DETERMINATION OF ORGANIC IMPURITIES OF DOCETAXEL IN PARENTERAL FORMULATION OF DOCETAXEL USING UV DETECTOR

LINGA REDDY MALLAMPATI R; JAGANMOHAN REDDY B

doi:10.22159/ajpcr.2024v17i9.50262

Authors

LINGA REDDY MALLAMPATI R LCGC Bioanalytic Solutions LLP, Hyderabad, Telangana, India https://orcid.org/0009-0002-1297-514X
JAGANMOHAN REDDY B Department of Chemistry, Adikavi Nannaya University, Rajamahendravaram, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2024v17i9.50262

Keywords:

Docetaxel, Organic impurities, Forced degradation, Validation,, High-performance liquid chromatography, Lung cancer.

Abstract

Objective: The objective is to develop a novel, rapid, simple, precise, accurate, and reproducible reverse-phase high-performance liquid chromatography (RP-HPLC) method for quantitative estimation of organic impurities of docetaxel (DTX) parenteral formulation through high-performance liquid chromatography (HPLC).

Methods: Finalized chromatographic conditions were used for a reversed-phase C18 column with particle size of 3 μm and dimension of 4.6×150 mm, water as mobile phase-A and acetonitrile mobile phase-B. The flow rate is 1.2 mL/min with gradient elution and ultraviolet (UV) detection at 232 nm. Acetonitrile: water:glacialcetic acid in the ratio of 100:100:0.1 (v/v/v) as diluent.

Results: Analytical test method for the quantitative determination of organic impurities of DTX in parenteral formulation of DTX using HPLC with UV detector was verified and found to be linear over the tested concentration range for all impurities (10-deacetylbaccatin: 0.032–0.466 μg/mL; DTX: 0.015–0.151 μg/mL; 6-oxodocetaxel: 0.023–2.080 μg/mL; 4-epidocetaxel: 0.022–1.380 μg/mL; 4-epi-6-oxodocetaxel: 0.021–0.673 μg/mL). The calibration charts plotted were linear with a regression coefficient of R2>0.999. Method-precise results were found to be within the acceptance criteria. Limit of detection and limit of quantification for the active ingredients and their impurities were established with respect to test concentration.

Conclusion: It was concluded that the method is simple, sensitive, precise, and accurate and hasthe ability to separate the drug from degradation products and excipients found in the dosage form.

Downloads

Download data is not yet available.

References

Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: A review. Anti Cancer Drugs. 2007;18(2):95-103. doi: 10.1097/CAD.0b013e3280113338, PMID 17159596

Hou W, Watters JW, Mcleod HL. Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. Analyt Technol Biomed Life Sci. 2004;804(2):263-7. doi: 10.1016/j. jchromb.2004.01.021, PMID 15081919

Andersen A, Warren DJ, Brunsvig PF, Aamdal S, Kristensen GB, Olsen H. High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. BMC Clin Pharmacol. 2006;6:2. doi: 10.1186/1472-6904-6-2, PMID 16412237

Kharkar P, Talkar S, Patravale V. A rapid and sensitive bio analytical RP-HPLC method for detection of docetaxel: Development and validation. Indian J Pharm Educ. 2017;51(4):729-34.

Wang L, Liu Z, Liu D, Liu C, Juan Z, Zhang N. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm. 2011;413(1- 2):194-201. doi: 10.1016/j.ijpharm.2011.04.023, PMID 21540085

Paterson HM, McCole D, Auld CD. Impact of open-access endoscopy on detection of early oesophageal and gastric cancer 1994-2003. Population based study. Endoscopy. 2006;38(5):503-7. doi: 10.1055/s- 2006-925124, PMID 16767587

Norris JM, Simpson BS, Freeman A, Kirkham A, Whitaker HC, Emberton M. Conspicuity of prostate cancer on multiparametric magnetic resonance imaging. A cross-disciplinary translational hypothesis. FASEB J. 2020;34(11):14150-9. doi: 10.1096/ fj.202001466R, PMID 32920937

Talari S, Anuradha V, Prathyusha AK. New validated RP-HPLC method for cisplatin and topotecan in API and vaccine form and its stress studies. Int J Res Pharm Sci. 2021;12:808-14.

Athavia AB, Dedania RZ, Dedania RR, Swamy SM, Prajapati CB. Stability indicating HPLC method for determination of vilazodone hydrochloride. Int J Curr Pharm Res. 2017;9:123-9.

Eliassen AH, Hankinson SE, Rosner B, Holmes MD, Willett WC. Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med. 2010;170(19):1758-64. doi: 10.1001/ archinternmed.2010.363, PMID 20975025

Gao FK, Sun J, Liu K, Liu X, He Z. Preparation and characterization of a submicron lipid emulsion of docetaxel: Submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm. 2008;34(11):1227-37. doi: 10.1080/03639040802005057, PMID 18720137

Mittal A, Chitkara D, Kumar N. HPLC method for the determination of carboplatin and paclitaxel with cremophorEL in an amphiphilic polymer matrix. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;855(2):211-9. doi: 10.1016/j.jchromb.2007.05.005, PMID 17543592

International Conference on Harmonization (ICH). Validation of Analytical Procedures. Methodology. Vol. Q2B; 1995. Available from: https://www.fda.gov/downloads/regulator%20yinformation/guidances/ ucm128049.pdf [Last accessed on 2011 Nov 12].

Kelmann RG, Kuminek G, Teixeira HF, Koester LS. Determination of carbamazepine in parenteral nanoemulsion: Development and validation of an HPLC method. Chromatographia. 2007;66(5- 6):427-30. doi: 10.1365/s10337-007-0314-7